

The Power of RNA Amplified
Impact measured in billions.
YOUR CELLs’ vERY OWN COPY MACHINERY
Our platform leverages next-generation self-replicating RNA (srRNA) vectors. Once inside cells, the genetic code of our srRNA drives repeated production of natural RNA, resulting in outsized protein expression and durable therapeutic effect.
OUR SCIENCe

ENABLING BROAd APPLICATIONs FOR RNA TREATMENTs
Replicate is advancing a robust pipeline of srRNA treatments spanning several therapeutic areas, including infectious disease, oncology, and autoimmune disorders. Improved performance over linear mRNA lets us help even more patients.
PIPELINe



News & Publications
11.04.23
Publications & Presentations
Self-replicating RNA therapeutics for the Off-the-Shelf Precision Immunotherapy targeting acquired resistance mutations in low TMB tumors
10.30.23
Press Releases
Replicate Bioscience to Present Progress on Two srRNA Oncology Programs at Society for Immunotherapy of Cancer 2023 Meeting
09.28.23
Perspectives
Dosing the first person with srRNA: Advancing a novel technology platform with a strategic development approach